DGX

178.24

7.08% 11.79

Handel nachbörslich: 178.24

Quest Diagnostics Inc (DGX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$166.45

Offen:

$170.625

24-Stunden-Volumen:

2.70M

Relative Volume:

2.38

Marktkapitalisierung:

$19.90B

Einnahmen:

$9.54B

Nettoeinkommen (Verlust:

$841.00M

KGV:

23.96

EPS:

7.44

Netto-Cashflow:

$1.02B

1W Leistung:

+7.10%

1M Leistung:

-0.66%

6M Leistung:

+17.64%

1J Leistung:

+20.96%

1-Tages-Spanne:

$170.03

$178.86

1-Wochen-Bereich:

$165.19

$178.86

52-Wochen-Spanne:

$137.71

$182.38

Quest Diagnostics Inc Stock (DGX) Company Profile

Firmenname

Quest Diagnostics Inc

Sektor

Healthcare (1161)

Branche

Diagnostics & Research (54)

Telefon

(973) 520-2700

Adresse

500 PLAZA DRIVE, SECAUCUS

Mitarbeiter

56,000

Twitter

@QuestDX

Nächster Verdiensttermin

2025-07-22

Neueste SEC-Einreichungen

DGX's Discussions on Twitter

Vergleichen Sie DGX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DGX Quest Diagnostics Inc	178.24	18.58B	9.54B	841.00M	1.02B	7.44
TMO Thermo Fisher Scientific Inc	427.62	157.79B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	189.91	138.02B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	532.00	42.36B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	116.19	32.08B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	187.38	27.28B	15.50B	1.33B	2.16B	7.34

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-02	Eingeleitet	Redburn Atlantic	Buy
2025-03-04	Herabstufung	Citigroup	Buy → Neutral
2025-01-06	Hochstufung	Leerink Partners	Market Perform → Outperform
2024-12-17	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	Fortgesetzt	Jefferies	Buy
2024-10-23	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-08-28	Fortgesetzt	Evercore ISI	In-line
2024-07-10	Hochstufung	Citigroup	Neutral → Buy
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2024-02-07	Hochstufung	Jefferies	Hold → Buy
2024-01-03	Eingeleitet	Barclays	Equal Weight
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-06-29	Eingeleitet	Piper Sandler	Neutral
2023-05-02	Herabstufung	BofA Securities	Buy → Neutral
2023-04-03	Hochstufung	Citigroup	Sell → Neutral
2023-01-23	Eingeleitet	Evercore ISI	In-line
2022-11-17	Herabstufung	Citigroup	Neutral → Sell
2022-08-22	Fortgesetzt	Morgan Stanley	Equal-Weight
2022-04-04	Herabstufung	Citigroup	Buy → Neutral
2022-02-23	Herabstufung	UBS	Buy → Neutral
2022-02-02	Herabstufung	Jefferies	Buy → Hold
2022-01-28	Herabstufung	Deutsche Bank	Buy → Hold
2021-05-04	Hochstufung	UBS	Neutral → Buy
2021-03-12	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-10-21	Hochstufung	Argus	Hold → Buy
2020-07-29	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Hochstufung	BofA Securities	Neutral → Buy
2020-06-09	Hochstufung	Wells Fargo	Underweight → Equal Weight
2020-06-02	Hochstufung	Deutsche Bank	Hold → Buy
2020-04-28	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Hochstufung	Citigroup	Neutral → Buy
2020-04-27	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-03-27	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Eingeleitet	Wells Fargo	Underweight
2020-01-07	Herabstufung	Barclays	Overweight → Equal Weight
2019-12-19	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-07-15	Herabstufung	Goldman	Neutral → Sell
2019-04-02	Hochstufung	Jefferies	Hold → Buy
2019-03-18	Fortgesetzt	Credit Suisse	Neutral
2019-01-31	Herabstufung	Argus	Buy → Hold
2019-01-17	Eingeleitet	UBS	Neutral
2019-01-03	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-12-03	Herabstufung	BofA/Merrill	Buy → Neutral
2018-11-30	Herabstufung	Goldman	Buy → Neutral

Alle ansehen

Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten

Jul 22, 2025

Quest Diagnostics Lifts Outlook As Testing Demand Grows - Finimize

Jul 22, 2025

Quest Diagnostics Surges to 241st in Daily Rankings with $476 Million Turnover - AInvest

Jul 22, 2025

What analysts say about Quest Diagnostics Incorporated stockExceptional earning trajectories - jammulinksnews.com

Jul 22, 2025

Is Quest Diagnostics Incorporated a good long term investmentDynamic capital growth - jammulinksnews.com

Jul 22, 2025

What drives Quest Diagnostics Incorporated stock priceSuperior trading gains - jammulinksnews.com

Jul 22, 2025

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch

Jul 22, 2025

Quest Diagnostics Well Positioned to Benefit From Strong Medical Utilization - Morningstar

Jul 22, 2025

Quest Diagnostics Q2 EarningsQuest Diagnostics (NYSE:DGX) - Benzinga

Jul 22, 2025

Quest Diagnostics Reports Strong Q2 Earnings, Exceeds ExpectationsNews and Statistics - IndexBox

Jul 22, 2025

Quest Diagnostics rises on upbeat results, guidance raise (DGX:NYSE) - Seeking Alpha

Jul 22, 2025

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand - whbl.com

Jul 22, 2025

Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises - The Globe and Mail

Jul 22, 2025

Quest Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 22, 2025

Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Jul 22, 2025

Quest Diagnostics: Q2 Earnings Snapshot - NewsTimes

Jul 22, 2025

Quest Diagnostics' Q2 2025 Earnings: A Strategic Analysis of Its Position in the Evolving Diagnostic Services Landscape - AInvest

Jul 22, 2025